Growth Metrics

Nu-Med Plus (NUMD) Depreciation & Amortization (IS) (2013 - 2022)

Nu-Med Plus recorded quarterly Depreciation & Amortization (IS) of $34.0 in Q3 2022, down 84.33% quarter-over-quarter from $217.0 in Q2 2022, and down 98.72% year-over-year from $2649.0 in Q3 2021.

Nu-Med Plus' Depreciation & Amortization (IS) history runs 5 years deep, the most recent figure standing at $34.0 for Q3 2022.

  • In Q3 2022, Depreciation & Amortization (IS) fell 98.72% year-over-year to $34.0; the TTM figure through Dec 2022 stood at $2266.0 (down 73.14% YoY), while the FY2022 annual figure was $2267.0, down 75.79% from the prior year.
  • Depreciation & Amortization (IS) came in at $34.0 for Q3 2022 at Nu-Med Plus, down from $217.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $2650.0 in Q4 2021 to a low of $34.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 310.25 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Nu-Med Plus - - - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2022 34.00
Jun 30, 2022 217.00
Mar 31, 2022 2,015.00
Dec 31, 2021 2,650.00
Sep 30, 2021 2,649.00
Jun 30, 2021 1,417.00
Dec 31, 2015 1,720.00
Sep 30, 2015 1,855.00
Jun 30, 2015 1,787.00
Mar 31, 2015 1,786.00
Dec 31, 2014 1,768.00
Sep 30, 2014 1,732.00
Jun 30, 2014 1,732.00
Mar 31, 2014 1,732.00
Dec 31, 2013 1,053.00
Sep 30, 2013 744.00
Jun 30, 2013 699.00
Mar 31, 2013 699.00